Duan et al., Clin Cancer Res 2004
(Osteosarcoma) :
The purpose of these studies was to determine whether alkylating agents affect the expression of Fas ligand (FasL) and whether interleukin 12 enhances the sensitivity of human OS cells to alkylating agents
Arshad et al., Hepatology 2012
(Acute Lung Injury...) :
We show that IL-33 expression in hepatocytes is partially controlled by perforin during acute liver injury, but not by TNFa or Fas ligand (FasL) ... Conclusion : The expression of IL-33 during acute hepatitis is dependent on TRAIL, but not on FasL or TNFa